{
  "trial_id": "NCT02081014",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, insulin infusion pump therapy status, hemoglobin A1c (HbA1c) levels, blood pressure (systolic and diastolic), history of cardiovascular events, pregnancy status, breastfeeding status, hepatitis B/C and HIV status, urine drug test results, history of allergies to glucagon or excipients, hereditary problems of glycogen storage disease, galactose and/or lactose intolerance, recent glucagon administration, hemoglobin levels, total bilirubin levels, aspartate aminotransferase (AST) levels, alanine aminotransferase (ALT) levels, creatinine levels, alcohol consumption history, participation in other studies, whole blood donation history, presence of severe acute or chronic medical or psychiatric conditions.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "HbA1c",
          "hemoglobin A1c (HbA1c) levels"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Region of Enrollment",
        "Body Weight",
        "Duration of Diabetes"
      ],
      "remaining_candidate_features": [
        "insulin infusion pump therapy status",
        "blood pressure (systolic and diastolic)",
        "history of cardiovascular events",
        "pregnancy status",
        "breastfeeding status",
        "hepatitis B/C and HIV status",
        "urine drug test results",
        "history of allergies to glucagon or excipients",
        "hereditary problems of glycogen storage disease",
        "galactose and/or lactose intolerance",
        "recent glucagon administration",
        "hemoglobin levels",
        "total bilirubin levels",
        "aspartate aminotransferase (AST) levels",
        "alanine aminotransferase (ALT) levels",
        "creatinine levels",
        "alcohol consumption history",
        "participation in other studies",
        "whole blood donation history",
        "presence of severe acute or chronic medical or psychiatric conditions"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, HbA1c, Blood Pressure, Duration of Diabetes, Insulin Pump Use, BMI, ",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "HbA1c",
          "HbA1c"
        ],
        [
          "Duration of Diabetes",
          "Duration of Diabetes"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Body Weight"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Blood Pressure",
        "Insulin Pump Use",
        "BMI"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Diabetes Diagnosis Duration, Insulin Infusion Pump Therapy, HbA1c, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, History of Cardiovascular Events,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "HbA1c",
          "HbA1c"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Body Weight",
        "Duration of Diabetes"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Diabetes Diagnosis Duration",
        "Insulin Infusion Pump Therapy",
        "Body Mass Index",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "History of Cardiovascular Events"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), duration of type 1 diabetes, HbA1c, insulin infusion pump therapy details, history of microvascular complications, blood pressure, cardiovascular disease history, thyroid hormone replacement status, laboratory test results (hemoglobin, total bilirubin, AST, ALT, creatinine), alcohol consumption history, pregnancy status, contraception method.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "HbA1c",
          "HbA1c"
        ],
        [
          "Body Weight",
          "body mass index (BMI)"
        ],
        [
          "Duration of Diabetes",
          "duration of type 1 diabetes"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "insulin infusion pump therapy details",
        "history of microvascular complications",
        "blood pressure",
        "cardiovascular disease history",
        "thyroid hormone replacement status",
        "laboratory test results (hemoglobin, total bilirubin, AST, ALT, creatinine)",
        "alcohol consumption history",
        "pregnancy status",
        "contraception method."
      ]
    }
  }
}